News

Chinese investors inject $45 million into South Australia health and biotech industry

The $45 million fund is backed by a group of private investors based in Nanjing, China. The group is led by Mr An LuFan, Executive Director of D&R Pharmaceuticals.

Dec 11, 2019

By : Team ABLE

Criteria for clinical trials might be too strict, needlessly excluding patients: UT Southwestern Medical Center findings

Clinical trial eligibility criteria are designed to limit risks to study participants. But, according to Dr. Gerber, these criteria may be excessive in places.

Dec 11, 2019

By : Team ABLE

Bill & Melinda Gates Foundation CEO Sue Desmond-Hellmann to step down; Mark Suzman appointed to role

Desmond-Hellmann made the decision to step away from full-time work after concluding that she could not adequately meet the demands of the position

Dec 09, 2019

By : Team ABLE

Lilly forms new leadership and strategy in oncology R&D

The new organization, named Loxo Oncology at Lilly, will be led jointly by Josh Bilenker, Jacob Van Naarden, andNisha Nanda, and will report into Daniel Skovronsky

Dec 09, 2019

By : Team ABLE

BIRAC announces special call of Biotech Ignition Grant for North East Region

Grant-in-aid support of up to INR 25 lakhs would be provided under the special call for BIG scheme

Dec 09, 2019

By : Team ABLE